Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

The food-delivery startup Maple has shut down

Leaked documents last year showed the company was in trouble.

Jason Del Rey
Jason Del Rey has been a business journalist for 15 years and has covered Amazon, Walmart, and the e-commerce industry for the last decade. He was a senior correspondent at Vox.

Maple, a New York City startup that had essentially built a delivery-only restaurant inside of an app, has shut down, the company announced to customers today.

The company had raised around $50 million, and possibly even more, in venture capital, and had chef David Chang of Momofuku fame advising it. But it had struggled to keep costs in check and prices affordable, leaked documents previously published by Recode showed.

In a note to customers on Monday, the company said “some members of the Maple team will join Deliveroo operations in London, and our technology will be used to help accelerate growth and efficiency across the platform.” Deliveroo is a heavily funded European food-delivery startup.

A Maple representative told Recode that the company’s co-founders, Caleb Merkl and Akshay Navle, as well as Chief Technology Officer Dan Cowgill, will be joining Deliveroo in London. Some other Maple employees may end up moving over, too.

With the shutdown, Maple becomes just the latest in a string of VC-backed food delivery startups to go under. SpoonRocket went out of business and Munchery has struggled.

These companies save money compared to traditional restaurants by not having to pay for brick-and-mortar storefronts. But it is expensive to retain and attract customers as a digital business, and the economics of on-demand delivery continue to be difficult to overcome. It doesn’t help that these companies have relatively low average order values for an e-commerce business.

In 2015, Maple was losing money on an average order, leaked documents showed. By March of 2016, gross margins were still just 2 percent.

Part of the company’s original pitch was that customers would pay a fixed price for a lunch or dinner meal that included all fees and tips. But last year, the company added a $1.95 delivery fee, a sure sign that the original model was not sustainable.

Maple was incubated inside of Thrive Capital, Josh Kushner’s well-regarded venture capital firm. The company’s other investors included Greenoaks Capital.


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh